SBZ Mrv0541 02231217252D 16 17 0 0 0 0 999 V2000 -1.4616 1.2489 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0 -0.9767 0.5815 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.2866 1.2489 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.2067 2.0335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.5416 2.0335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8741 2.5184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1562 0.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3287 0.0002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1492 0.0865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0069 -0.7534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6341 -0.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4781 -1.4209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2985 -1.3346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7835 -2.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6039 -1.9158 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 1.4479 -2.7557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 0 0 0 0 1 4 1 0 0 0 0 2 7 1 0 0 0 0 3 5 1 0 0 0 0 4 6 1 0 0 0 0 5 6 1 0 0 0 0 7 8 1 0 0 0 0 8 9 2 0 0 0 0 8 10 1 0 0 0 0 9 11 1 0 0 0 0 10 12 2 0 0 0 0 11 13 2 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 2 0 0 0 0 14 16 1 0 0 0 0 M CHG 1 15 1 M END > DB04109 > drugbank > NC(=[NH2+])C1=CC=C(COB2OCCO2)C=C1 > InChI=1S/C10H13BN2O3/c12-10(13)9-3-1-8(2-4-9)7-16-11-14-5-6-15-11/h1-4H,5-7H2,(H3,12,13)/p+1 > XCLFQXCQQHVLJQ-UHFFFAOYSA-O > C10H14BN2O3 > 221.041 > 221.10974779 > 4 > 30 > 0.9999663605994443 > 24.278690452659077 > 1 > 2 > 1 > 1 > [amino({4-[(1,3,2-dioxaborolan-2-yloxy)methyl]phenyl})methylidene]azanium > -0.50 > 2.268 > -2.81 > 0 > 1 > 2 > 1 > 11.473136967106381 > 79.3 > 66.2568 > 4 > 1 > 4.00e-01 g/l > tetrahydrofolic acid > 0 > DB04109 > EXPT02862 > experimental > [4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine $$$$